KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $1.7 billion.

  • Gilead Sciences' Other Operating Expenses fell 5458.34% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 billion, marking a year-over-year decrease of 5719.28%. This contributed to the annual value of $15.1 billion for FY2024, which is 9594.96% up from last year.
  • Gilead Sciences' Other Operating Expenses amounted to $1.7 billion in Q3 2025, which was down 5458.34% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Other Operating Expenses ranged from a high of $8.1 billion in Q1 2024 and a low of $1.3 billion during Q3 2021
  • For the 5-year period, Gilead Sciences' Other Operating Expenses averaged around $2.4 billion, with its median value being $1.8 billion (2025).
  • Per our database at Business Quant, Gilead Sciences' Other Operating Expenses skyrocketed by 33131.31% in 2024 and then plummeted by 7789.97% in 2025.
  • Over the past 5 years, Gilead Sciences' Other Operating Expenses (Quarter) stood at $3.3 billion in 2021, then plummeted by 52.85% to $1.6 billion in 2022, then skyrocketed by 59.97% to $2.5 billion in 2023, then plummeted by 36.89% to $1.6 billion in 2024, then increased by 10.83% to $1.7 billion in 2025.
  • Its Other Operating Expenses was $1.7 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.8 billion in Q1 2025.